Cravath’s London Office Moves to 100 Cheapside
September 27, 2021
On September 23, 2021, Cravath partner John W. White participated in the Garrett and Corporate Counsel Institute, which was hosted virtually by the Northwestern Pritzker School of Law. John spoke on a panel of former U.S. Securities and Exchange Commission directors entitled “‘Changes in Latitudes, Changes in Attitudes’ — The SEC Under Biden.” John and his fellow panelists discussed the key priorities of the Divisions of Corporation Finance and Enforcement, focusing on ESG disclosure rulemaking, cybersecurity disclosure, Rule 10b5‑1 plans, proxy matters and where the SEC may be headed on these and other rulemaking initiatives.
Deals & Cases
July 29, 2021
Cravath represented Robinhood in connection with its initial public offering. Robinhood raised approximately $1.9 billion of net proceeds in the IPO. Shares began trading on July 29, 2021 on the NASDAQ exchange.
Deals & Cases
November 17, 2020
On November 17, 2020, Deutsche Börse AG, Institutional Shareholder Services Inc. (“ISS”) and Genstar Capital LLC announced that Deutsche Börse will acquire approximately 80% of leading governance, ESG data and analytics provider ISS, valuing ISS at $2.275 billion for 100% of the business. Genstar Capital and current management will continue to hold a stake of approximately 20%. Cravath, alongside Hengeler Mueller, is representing Deutsche Börse in connection with the transaction.
Deals & Cases
September 30, 2020
Cravath represented the Founders of Palantir Technologies Inc. (“Palantir”) in connection with Palantir’s direct listing and the structuring and negotiation of the governance structure. Palantir develops and builds data‑logic platforms for governmental and commercial institutions and people. Shares began trading on the New York Stock Exchange on September 30, 2020.
Deals & Cases
April 01, 2020
Cravath represented Akorn, Inc. in connection with the issuance of 6,713,905 shares of common stock and equal number of series A contingent value rights. Akorn, Inc. is a U.S.‑based manufacturer and marketer of prescription and over‑the‑counter pharmaceutical products. This issuance is in connection with a settlement agreement entered into by Akorn, Inc. and other defendants to resolve a securities class action lawsuit. The transaction closed on April 1, 2020.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.